Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Oct;71(10):7312–7317. doi: 10.1128/jvi.71.10.7312-7317.1997

Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.

J Enssle 1, N Fischer 1, A Moebes 1, B Mauer 1, U Smola 1, A Rethwilm 1
PMCID: PMC192075  PMID: 9311808

Abstract

Foamy viruses (FVs) express the Gag protein as a precursor with a molecular mass of 74 kDa (pr74) from which a 70-kDa protein (p70) is cleaved by the viral protease. To gain a better understanding of FV Gag protein processing and function, we have generated and analyzed mutants in the C-terminal gag region of an infectious molecular clone. Our results show that p70 is an N-terminal cleavage product of pr74. However, we were unable to identify a p4 molecule. A virus mutant expressing p70 only was found to be replication competent, albeit at very low titers compared to those of wild-type virus. A strong tendency to synthesize and cleave a pr74 molecule was deduced from the occurrence of revertants upon transfection of this mutant. Substitution of the p6gag domain of human immunodeficiency virus type 1 for the p4 domain of FV resulted in a stable chimeric virus which replicated to titers 10 times lower than those of wild-type virus. FV Gag protein was found to be phosphorylated at serine residues. Mutagenesis of serines conserved in the p4 domain had no influence on viral replication in cell culture. The p70/p74 Gag cleavage was found to be required for viral infectivity, since mutagenesis of the putative cleavage site led to replication-incompetent virus. Interestingly, the cleavage site mutants were defective in the intracellular cDNA synthesis of virion DNA, which indicates that correct FV particle formation and the generation of virion DNA are functionally linked.

Full Text

The Full Text of this article is available as a PDF (990.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baunach G., Maurer B., Hahn H., Kranz M., Rethwilm A. Functional analysis of human foamy virus accessory reading frames. J Virol. 1993 Sep;67(9):5411–5418. doi: 10.1128/jvi.67.9.5411-5418.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bieniasz P. D., Weiss R. A., McClure M. O. Cell cycle dependence of foamy retrovirus infection. J Virol. 1995 Nov;69(11):7295–7299. doi: 10.1128/jvi.69.11.7295-7299.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodem J., Löchelt M., Winkler I., Flower R. P., Delius H., Flügel R. M. Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J Virol. 1996 Dec;70(12):9024–9027. doi: 10.1128/jvi.70.12.9024-9027.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyle W. J., van der Geer P., Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 1991;201:110–149. doi: 10.1016/0076-6879(91)01013-r. [DOI] [PubMed] [Google Scholar]
  5. Campbell M., Eng C., Luciw P. A. The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene. J Virol. 1996 Oct;70(10):6847–6855. doi: 10.1128/jvi.70.10.6847-6855.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Duclos B., Marcandier S., Cozzone A. J. Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Methods Enzymol. 1991;201:10–21. doi: 10.1016/0076-6879(91)01004-l. [DOI] [PubMed] [Google Scholar]
  7. Enssle J., Jordan I., Mauer B., Rethwilm A. Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4137–4141. doi: 10.1073/pnas.93.9.4137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Freed E. O., Englund G., Maldarelli F., Martin M. A. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell. 1997 Jan 24;88(2):171–174. doi: 10.1016/s0092-8674(00)81836-x. [DOI] [PubMed] [Google Scholar]
  9. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 1995 Feb 10;80(3):379–388. doi: 10.1016/0092-8674(95)90488-3. [DOI] [PubMed] [Google Scholar]
  10. Giron M. L., Colas S., Wybier J., Rozain F., Emanoil-Ravier R. Expression and maturation of human foamy virus Gag precursor polypeptides. J Virol. 1997 Feb;71(2):1635–1639. doi: 10.1128/jvi.71.2.1635-1639.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goepfert P. A., Shaw K. L., Ritter G. D., Jr, Mulligan M. J. A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J Virol. 1997 Jan;71(1):778–784. doi: 10.1128/jvi.71.1.778-784.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goepfert P. A., Wang G., Mulligan M. J. Identification of an ER retrieval signal in a retroviral glycoprotein. Cell. 1995 Aug 25;82(4):543–544. doi: 10.1016/0092-8674(95)90026-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  14. Göttlinger H. G., Dorfman T., Sodroski J. G., Haseltine W. A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195–3199. doi: 10.1073/pnas.88.8.3195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hahn H., Baunach G., Bräutigam S., Mergia A., Neumann-Haefelin D., Daniel M. D., McClure M. O., Rethwilm A. Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol. 1994 Oct;75(Pt 10):2635–2644. doi: 10.1099/0022-1317-75-10-2635. [DOI] [PubMed] [Google Scholar]
  16. Jordan I., Enssle J., Güttler E., Mauer B., Rethwilm A. Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA. Virology. 1996 Oct 1;224(1):314–319. doi: 10.1006/viro.1996.0534. [DOI] [PubMed] [Google Scholar]
  17. Kondo E., Mammano F., Cohen E. A., Göttlinger H. G. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol. 1995 May;69(5):2759–2764. doi: 10.1128/jvi.69.5.2759-2764.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Konvalinka J., Löchelt M., Zentgraf H., Flügel R. M., Kräusslich H. G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol. 1995 Nov;69(11):7264–7268. doi: 10.1128/jvi.69.11.7264-7268.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Löchelt M., Flügel R. M. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol. 1996 Feb;70(2):1033–1040. doi: 10.1128/jvi.70.2.1033-1040.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Merkulov G. V., Swiderek K. M., Brachmann C. B., Boeke J. D. A critical proteolytic cleavage site near the C terminus of the yeast retrotransposon Ty1 Gag protein. J Virol. 1996 Aug;70(8):5548–5556. doi: 10.1128/jvi.70.8.5548-5556.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moebes A., Enssle J., Bieniasz P. D., Heinkelein M., Lindemann D., Bock M., McClure M. O., Rethwilm A. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol. 1997 Oct;71(10):7305–7311. doi: 10.1128/jvi.71.10.7305-7311.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Morozov V. A., Copeland T. D., Nagashima K., Gonda M. A., Oroszlan S. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Virology. 1997 Feb 17;228(2):307–317. doi: 10.1006/viro.1996.8379. [DOI] [PubMed] [Google Scholar]
  23. Netzer K. O., Rethwilm A., Maurer B., ter Meulen V. Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol. 1990 May;71(Pt 5):1237–1241. doi: 10.1099/0022-1317-71-5-1237. [DOI] [PubMed] [Google Scholar]
  24. Netzer K. O., Schliephake A., Maurer B., Watanabe R., Aguzzi A., Rethwilm A. Identification of pol-related gene products of human foamy virus. Virology. 1993 Jan;192(1):336–338. doi: 10.1006/viro.1993.1039. [DOI] [PubMed] [Google Scholar]
  25. Parent L. J., Bennett R. P., Craven R. C., Nelle T. D., Krishna N. K., Bowzard J. B., Wilson C. B., Puffer B. A., Montelaro R. C., Wills J. W. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J Virol. 1995 Sep;69(9):5455–5460. doi: 10.1128/jvi.69.9.5455-5460.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Peden K., Emerman M., Montagnier L. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology. 1991 Dec;185(2):661–672. doi: 10.1016/0042-6822(91)90537-l. [DOI] [PubMed] [Google Scholar]
  27. Rethwilm A. Unexpected replication pathways of foamy viruses. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 (Suppl 1):S248–S253. doi: 10.1097/00042560-199600001-00037. [DOI] [PubMed] [Google Scholar]
  28. Russell D. W., Miller A. D. Foamy virus vectors. J Virol. 1996 Jan;70(1):217–222. doi: 10.1128/jvi.70.1.217-222.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Saïb A., Puvion-Dutilleul F., Schmid M., Périès J., de Thé H. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol. 1997 Feb;71(2):1155–1161. doi: 10.1128/jvi.71.2.1155-1161.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schliephake A. W., Rethwilm A. Nuclear localization of foamy virus Gag precursor protein. J Virol. 1994 Aug;68(8):4946–4954. doi: 10.1128/jvi.68.8.4946-4954.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schmidt M., Rethwilm A. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology. 1995 Jun 20;210(1):167–178. doi: 10.1006/viro.1995.1328. [DOI] [PubMed] [Google Scholar]
  32. Weiss R. A. Reverse transcription. Foamy viruses bubble on. Nature. 1996 Mar 21;380(6571):201–201. doi: 10.1038/380201a0. [DOI] [PubMed] [Google Scholar]
  33. Yu S. F., Baldwin D. N., Gwynn S. R., Yendapalli S., Linial M. L. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science. 1996 Mar 15;271(5255):1579–1582. doi: 10.1126/science.271.5255.1579. [DOI] [PubMed] [Google Scholar]
  34. Yu S. F., Edelmann K., Strong R. K., Moebes A., Rethwilm A., Linial M. L. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J Virol. 1996 Dec;70(12):8255–8262. doi: 10.1128/jvi.70.12.8255-8262.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES